Data currently available reveal that miR-100-5p and miR-125b-5p can promote tumor cell proliferation and invasion, at the same time being related to survival time as they can negatively affect patient response to treatment with BRAF inhibitors such as vemurafenib [6,9,30]. Here, BRAF is linked to neoplasm.